Close
0
Inquiry Basket

There is no product in the shopping cart, buy it!

Hot Products
Monosaccharide Products
Oligosaccharide Products
Polysaccharide Products
Carbohydrate-based Surfactant Products
Blood Group Antigen Products
Glycoprotein Products
Glycopeptide Products
Nucleotide Sugar Products
Glycoprotein Assay Kits
Comprehensive Glycoprotein Reagents
Glycoengineered Cell Products
Glycoengineering Viral Particle Products
Glycolipid Products

Recombinant Bat coronavirus RaTG13 Spike glycoprotein (Val16-Lys1209) [His tag], CHO

CAT#: GP05-093J

Datasheet Request COA
Specifications Target Information Related Products
Specifications
Product Overview
Recombinant Bat coronavirus RaTG13 Spike glycoprotein (QHR63300.2) (Val16-Lys1209) was produced in CHO cells with a 6-His tag at the C-terminus. Measured by its binding ability in a functional ELISA with recombinant human ACE-2.
Biological Activity
Measured by its binding ability in a functional ELISA with recombinant human ACE-2.
Source
CHO cells
Species
Bat coronavirus RaTG13
Fragment
Val16-Lys1209
Tag
6-His tag at the C-terminus
Predicted N Terminal
Val 16
Predicted MW
134 kDa
Purity
>95%, determined by SDS-PAGE.
Endotoxin Level
<0.1 EU/μg, determined by LAL method.
Conjugation
Unconjugated
Target Information
Target
S
Full Name
Spike glycoprotein
Accession Number
QHR63300.2
Background
Bat virus RaTG13 was identified as the closest known relative of SARS-CoV-2. The S protein mediates attachment of the virus to cell-surface receptors and fusion between virus and cell membranes.
Alternate Names
Spike glycoprotein
For Research Use Only.
Online Inquiry
Copyright © Creative Biolabs. All Rights Reserved.